Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,151
Recruiting: 2,258
Ph III recruiting: 267
Growth YoY: +13.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 101–150 of 612 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05017662	A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072	completed	N/A	20	Ariceum Therapeutics GmbHINDUSTRY	6	Sep 4, 2025	clinicaltrials
NCT03552965	Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC	completed	N/A	23	University of ArkansasOTHER	1	Sep 2, 2025	clinicaltrials